Top 10 Key Players in India ADHD Medication Market | Competitive Landscape 2026

Code: MTA12927 Publication Date: Jun 2026

Top 10 Key Players in India ADHD Medication Market

India ADHD medication market is a rapidly growing segment of the country’s pharmaceutical and neuropsychiatric therapeutics sector, supporting better patient outcomes and cognitive management. Key players in the market are Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Eli Lilly and Company, Novartis AG, and Aurobindo Pharma.

India ADHD Medication Market Overview

According to 6Wresearch, the India ADHD medication market is experiencing significant growth due to increasing awareness of ADHD, expanded diagnostic facilities, and rising prescription rates for stimulant and non-stimulant therapies. Market growth is driven by government efforts to improve mental health care infrastructure and an increasing focus on pediatric and adolescent neurodevelopmental disorders.

Competitive Landscape

The competitive landscape of India ADHD medication market includes both multinational pharmaceutical giants and established domestic players. These companies offer diverse product portfolios ranging from generic stimulants to branded non-stimulant formulations, ensuring access to quality treatments across urban and rural regions.

Leading Players Operating in the India ADHD Medication Market:

1. Sun Pharmaceutical Industries

Company NameSun Pharmaceutical Industries
Established Year1983
HeadquartersMumbai, India
Official WebsiteClick Here

Sun Pharmaceutical Industries A global pioneer in the CNS segment, Sun Pharma provides sophisticated therapeutic solutions that handle complex neurochemical regulation and large-scale patient health management.

2. Torrent Pharmaceuticals

Company NameTorrent Pharmaceuticals
Established Year1959
HeadquartersAhmedabad, India
Official WebsiteClick Here

Torrent Pharmaceuticals A major force in the regional space, Torrent focuses on precision psychotropic compliance and evidence-based automation for large-scale neurological care.

3. Eli Lilly and Company

Company NameEli Lilly and Company
Established Year1876
HeadquartersIndianapolis, USA
Official WebsiteClick Here

Eli Lilly and Company A historic innovator in psychiatric research, Eli Lilly is renowned for being among the first to offer high-efficacy non-stimulant therapies for pediatric ADHD management.

4. Novartis AG

Company NameNovartis AG
Established Year1996
HeadquartersBasel, Switzerland
Official WebsiteClick Here

Novartis AG A fast-growing leader in the neuro-psychiatric segment that provides an end-to-end cognitive enhancement suite, integrating pharmacological precision with behavioral patient monitoring.

5. Aurobindo Pharma

Company NameAurobindo Pharma
Established Year1986
HeadquartersHyderabad, India
Official WebsiteClick Here

Aurobindo Pharma A mobile-first pharmaceutical platform that leverages global distribution data to provide high-precision therapy management for diverse psychiatric industries.

6. Zydus Lifesciences

Company NameZydus Lifesciences
Established Year1952
HeadquartersAhmedabad, India
Official WebsiteClick Here

Zydus Lifesciences Part of the global neurological ecosystem, this brand focuses on providing affordable, highly customizable neuro-therapeutics integrated with broad mental health applications.

7. Glenmark Pharmaceuticals

Company NameGlenmark Pharmaceuticals
Established Year1977
HeadquartersMumbai, India
Official WebsiteClick Here

Glenmark Pharmaceuticals A leader in generic therapeutic solutions, focusing on metabolic and nervous system health through advanced pharmaceutical science for chronic patient care.

8. Alembic Pharmaceuticals

Company NameAlembic Pharmaceuticals
Established Year1907
HeadquartersVadodara, India
Official WebsiteClick Here

Alembic Pharmaceuticals Provides robust neurological support, combining legacy manufacturing standards with modern evidence-based efficacy for complex ADHD management.

9. Lupin

Company NameLupin
Established Year1968
HeadquartersMumbai, India
Official WebsiteClick Here

Lupin A global player in the generic pharmaceutical space, supporting the Indian healthcare sector with diverse therapeutic formulations and mental health support initiatives.

10. Cipla

Company NameCipla
Established Year1935
HeadquartersMumbai, India
Official WebsiteClick Here

Cipla A foundational leader in the Indian pharmaceutical ecosystem, delivering high-quality, accessible medications for neuro-developmental and systemic health.

Top 10 Key Players in India ADHD Medication Market: FAQs

Major players in the India ADHD medication market are Sun Pharmaceutical, Torrent Pharmaceuticals, Eli Lilly and Company, Novartis AG, and Aurobindo Pharma.
Companies expand their presence through hospital partnerships, physician training, and nationwide distribution networks.
Leading firms develop extended-release, non-stimulant, and combination therapies while integrating patient-centric designs for better adherence.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All